Related Experiment Video
Updated: Feb 14, 2026

A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
Published on: February 28, 2019
CD80/CD86 signaling contributes to the proinflammatory response of Staphylococcus aureus in the airway
1Department of Pediatrics, Columbia University, New York, NY, USA.
Abstract:
It was posited that the initial host response to Staphylococcus aureus is a contributing factor in the pathogenesis of acute pneumonia. Having previously observed that T cells play a negative role in the pathogenesis of acute pneumonia to S. aureus the contribution of the CD80/CD86 pathway in pathogenesis was investigated. Mice lacking CD80 and CD86 had significantly improved survival in a mouse model of acute S. aureus pneumonia. This was accompanied by significant reductions in several proinflammatory cytokines, including TNF, MIP-2, IL-1β, IL-17 and IL-6, as well as increased numbers of viable alveolar macrophages. Early during infection reductions in cytokine production were evident and cytokine production in response to S. aureus in bone marrow derived macrophages showed decreases in TNF, KC, IL-1α and GM-CSF. Our data suggest that CD80/CD86 signaling plays a significant role in the initial inflammatory response to S. aureus in the airway and could be a potential acute target to reduce the initial inflammatory insult.
Insights
Blocking the CD80/CD86 pathway improves survival in Staphylococcus aureus pneumonia. This approach reduces harmful inflammation and increases protective macrophages, offering a potential therapeutic target.
Area of Science:
- Immunology
- Pulmonology
- Microbiology
Background:
- The initial host response to Staphylococcus aureus (S. aureus) contributes to acute pneumonia pathogenesis.
- T cells have a negative role in S. aureus-induced pneumonia.
- The CD80/CD86 pathway's role in this pathogenesis requires investigation.
Purpose of the Study:
- To investigate the contribution of the CD80/CD86 pathway in the pathogenesis of acute S. aureus pneumonia.
- To evaluate the therapeutic potential of targeting CD80/CD86 signaling.
Main Methods:
- Utilized a mouse model of acute S. aureus pneumonia.
- Compared survival rates and inflammatory responses between wild-type and CD80/CD86-deficient mice.
- Analyzed cytokine production in vivo and in bone marrow-derived macrophages.
Main Results:
- Mice lacking CD80 and CD86 exhibited significantly improved survival.
- Absence of CD80/CD86 led to reduced levels of pro-inflammatory cytokines (TNF, MIP-2, IL-1β, IL-17, IL-6).
- Increased numbers of viable alveolar macrophages were observed in CD80/CD86-deficient mice.
- Early reductions in cytokine production and decreased responses to S. aureus in macrophages were noted.
Conclusions:
- CD80/CD86 signaling significantly influences the initial airway inflammatory response to S. aureus.
- Targeting the CD80/CD86 pathway may mitigate the initial inflammatory insult in S. aureus pneumonia.
- This pathway represents a potential therapeutic target for acute pneumonia treatment.
Related Concept Videos
Diversity in Cell Signaling Responses
Graded and Abrupt Responses
Some signaling systems generate...
Binet's Contribution to Measures of Intelligence
Wechsler's Contribution to Measures of Intelligence
Suctioning the Nasopharyngeal Airway
Equipment Required
Suctioning the Oropharyngeal Airway
After assembling the equipment, the nurse should practice hand hygiene and don appropriate PPE according to infection control guidelines to avoid the...
What is Cell Signaling?

